Urine Proteome of Surgical Patients and Healthy Volunteers

Urine Proteome of Surgical Patients and Healthy Volunteers.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01538823

Acronym

Enrollment

664

Registered

2012-02-24

Start date

2012-02-29

Completion date

2016-07-31

Last updated

2019-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Cell Cancer

Keywords

Surgery, Renal Cell Cancer

Brief summary

The purpose of this study is to define early urinary biomarkers for diagnosis and prognosis of Renal Cell Carcinoma (RCC) with subsequent development of reliable, cost-effective, screening techniques.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years and older * Planned procedure with presumptive diagnosis of RCC, bladder or prostate cancer OR control patient undergoing non-urological surgery OR normal healthy volunteer OR post surgical patient with a diagnosis of RCC and under surveillance for reoccurrence of RCC or treatment of metastatic RCC * Signed, informed consent

Exclusion criteria

* Patients on dialysis

Design outcomes

Primary

Measure	Time frame	Description
evaluation of novel bio markers	5 years	The overall objective of our study is to find and evaluate additional novel biomarkers, predictive of disease, that are present and measurable in whole urine of patients undergoing surgery for renal cancer.

Countries

United States

Outcome results